Brief: Immutep Announces Positive Feedback Received From US FDA
22/07/2024 02:43
July 22 (Reuters) - Immutep Ltd IMM.AX :
* POSITIVE FEEDBACK RECEIVED FROM US FDA
* FEEDBACK ON PHASE III DESIGN IN NON-SMALL CELL LUNG CANCER
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))